about
Spatial Genome Organization and Its Emerging Role as a Potential Diagnosis ToolIncreased Dietary Inflammatory Index (DII) Is Associated With Increased Risk of Prostate Cancer in Jamaican MenDesign and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)Prostate cancer outcomes in France: treatments, adverse effects and two-year mortalityAmerican trends in expectant management utilization for prostate cancer from 2000 to 2009.The increase in cancer prevalence and hospital burden in Western Australia, 1992-2011.A combined index to classify prognostic comorbidity in candidates for radical prostatectomyHuman papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis.Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia.Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error.A hospital-based study of initial observation for low-risk prostate cancer and its predictors in the United StatesDesigning Normative Messages About Active Surveillance for Men With Localized Prostate Cancer.Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening.From evidence to best practice in laboratory medicineMapping of prostate cancer by 1H MRSI.Cancer mortality and other causes of death in users of geothermal hot water.Experience of US Patients Who Self-identify as Having an Overdiagnosed Thyroid Cancer: A Qualitative Analysis.Prostate cell lines as models for biomarker discovery: performance of current markers and the search for new biomarkers.Prostate cancer screening in a low prevalence population. Is it worth it?Long-term differences in urinary, bowel and sexual function among men treated with surgery versus radiation for prostate cancer.Screening and overdiagnosis: public health implications.An exponential growth in incidence of thyroid cancer: trends and impact of CT imaging.Photoacoustic tomography of intact human prostates and vascular texture analysis identify prostate cancer biopsy targets
P2860
Q26738275-179ABB19-FF15-46BC-B148-AB225335C32BQ28390566-DBC25880-3B9D-44D3-A31A-2AE140F7A2EAQ33750148-348B51B3-83E2-4140-9E84-BD0AA438BD11Q33795089-4A5A920E-4C18-4DC9-BFCA-E0BE0FA64064Q34602118-EF4BDA22-825A-4A6F-B132-404FD49C352BQ34986518-1AB04685-9FDC-42C9-B893-393ACE0233ABQ35134283-B81A3145-06A8-4871-BFD0-FD2ACF792167Q35211033-7462EFE3-E079-41FE-8DC7-58950B2E4E4DQ35535819-CE931640-EA23-4666-BACE-ACA1BA438BD6Q35678391-D07412D8-754B-4569-88C6-C1967F43FBCBQ36414849-BFB70C16-E425-49B9-ACA2-BC96FC44B0E0Q36668945-41C99FCE-8E4B-4E8F-97E4-CD25294F3B31Q36901009-544390F7-182B-4EFB-B10B-71E2595B8906Q37236075-4AF007DF-7378-4509-B964-FCA873385404Q38114017-EB51149B-030C-45E2-9117-BA58B2E6ED30Q38428700-F1DA3AFA-1240-4D97-98D4-3308D6DC6985Q38917491-5DEDDFF7-F3EB-4FA6-87F2-60BB27C323A7Q39033586-4D4192C3-F136-4841-B677-D040D1846EA8Q41391210-20BDB650-F2E3-47DD-AC46-743429E5B047Q42140340-7667EF7D-2E1D-46B6-A311-260770E7A2B2Q49622683-E8614AED-FEDF-4AB9-A840-6318443A5F1FQ51227102-88CB3C53-ABB5-468A-AEE7-BFAA2BBB5433Q58801432-7BFA2DAF-EEAD-499A-A48D-6E8224E20CB8
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Overdiagnosis of prostate cancer.
@ast
Overdiagnosis of prostate cancer.
@en
type
label
Overdiagnosis of prostate cancer.
@ast
Overdiagnosis of prostate cancer.
@en
prefLabel
Overdiagnosis of prostate cancer.
@ast
Overdiagnosis of prostate cancer.
@en
P2860
P356
P1476
Overdiagnosis of prostate cancer.
@en
P2093
Gerald L Andriole
Gurdarshan S Sandhu
P2860
P304
P356
10.1093/JNCIMONOGRAPHS/LGS031
P577
2012-12-01T00:00:00Z